A clinical decision instrument to predict 30-day death and cardiovascular hospitalizations after an emergency department visit for atrial fibrillation: The Atrial Fibrillation in the Emergency Room, Part 2 (AFTER2) study - 06/09/18
, Paul Dorian, MD, MSc e, f, Jiming Fang, PhD a, Jack V Tu, MD, MSc, PhD a, c, d, g, Douglas S Lee, MD, PhD a, d, e, h, Alice S Chong, BSc a, Peter C Austin, PhD a, c, dAbstract |
Background |
In previous work, we derived and validated a tool that predicts 30-day mortality in emergency department atrial fibrillation (AF) patients. The objective of this study was to derive and validate a tool that predicts a composite of 30-day mortality and return cardiovascular hospitalizations.
Methods |
This retrospective cohort study at 24 emergency departments in Ontario, Canada, included patients with a primary diagnosis of AF who were seen between April 2008 and March 2009. We assessed a composite outcome of 30-day mortality and subsequent hospitalizations for a cardiovascular reason, including stroke.
Results |
Of 3,510 patients, 2,343 were randomly selected for the derivation cohort, leaving 1,167 in the validation cohort. The composite outcome occurred in 227 (9.7%) and 125 (10.7%) patients in the derivation and validation cohorts, respectively. Eleven variables were independently associated with the outcome: older age, not taking anticoagulation, HAS-BLED score of ≥3, 3 laboratory results (positive troponin, supratherapeutic international normalized ratio, and elevated creatinine), emergency department administration of furosemide, and 4 patient comorbidities (heart failure, chronic obstructive lung disease, cancer, dementia). In the validation cohort, the observed 30-day outcomes in the 5 risk strata that were defined using the derivation cohort were 2.0%, 6.6%, 10.7%, 12.5%, and 20.0%. The c statistic was 0.73 and 0.69 in the derivation and validation cohort, respectively.
Conclusions |
Using a population-based sample, we derived and validated a tool that predicts the risk of early death and rehospitalization for a cardiovascular reason in emergency department AF patients. The tool can offer information to managing physicians about the risk of death and rehospitalization for AF patients seen in the in emergency department, as well as identify patient groups for future targeted interventions aimed at preventing these outcomes.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
The Atrial Fibrillation in the Emergency Room, Part 2 (AFTER2) Study.
Plan
| Declarations of interest: None. |
|
| Funding: This study was funded by a Grant-in-Aid from the Heart and Stroke Foundation (NA7072). Dr. Atzema was supported by a New Investigator Award from the Heart and Stroke Foundation (HSF), the Practice Plan of the Department of Emergency Services at Sunnybrook Health Sciences, and the Sunnybrook Research Institute. Dr Dorian is supported by a CANet Program grant, as part of the Networks of Centres of Excellence (NCE). Dr Tu was supported by a Tier 1 Canada Research Chair in Health Services Research and an Eaton Family Scholar award. Dr. Lee was supported by the Ted Rogers Chair in Heart Function Outcomes and a Mid-Career Investigator award from the HSF. Dr. Austin is supported by a Career Investigator Award from the HSF. |
|
| This study was presented at the Canadian Cardiovascular Congress in Vancouver; October 26, 2015. |
Vol 203
P. 85-92 - septembre 2018 Retour au numéro
Article précédent
- Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery
- Danielle M Gualandro, Christian Puelacher, Giovanna LuratiBuse, Andreas Lampart, Celia Strunz, Francisco A Cardozo, Pai C Yu, Allan S Jaffe, Sanela Barac, Lukas Bock, Patrick Badertscher, Jeanne du Fay de Lavallaz, Stella Marbot, Lorraine Sazgary, Daniel Bolliger, Katharina Rentsch, Raphael Twerenbold, Angelika Hammerer-Lercher, Edielle S Melo, Daniela Calderaro, Alberto JS Duarte, Nelson de Luccia, Bruno Caramelli, Christian Mueller, TropoVasc and BASEL-PMI Investigators
- First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization
- Adriana Luk, John D. Groarke, Akshay S. Desai, Syed Saad Mahmood, Deepa M. Gopal, Emer Joyce, Sachin P. Shah, Joann Lindenfeld, Lynne Stevenson, Neal K. Lakdawala
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?